Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians
The use of imaging in colorectal cancer (CRC) has significantly evolved over the last twenty years, establishing important roles in surveillance, diagnosis, staging, treatment selection and follow up. The range of modalities has broadened with the development of novel tracer and contrast agents, and...
Main Authors: | Eric Van Cutsem, Henk M. W. Verheul, Patrik Flamen, Philippe Rougier, Regina Beets-Tan, Rob Glynne-Jones, Thomas Seufferlein |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/8/9/81 |
Similar Items
-
Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice
by: Eleonora Lai, et al.
Published: (2021-05-01) -
Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model
by: Michela Murdocca, et al.
Published: (2019-09-01) -
The use of regorafenib in colorectal cancer
by: Marina I Sekacheva, et al.
Published: (2019-06-01) -
Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment
by: Claudia S. E. W. Schuurhuizen, et al.
Published: (2019-02-01) -
KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer – practical implications for the clinician
by: Afrăsânie Vlad-Adrian, et al.
Published: (2019-09-01)